Iris Ponton

Ms. Iris Ponton


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2018 in Catalysts
Verified
Journal Article
Open access
PDF file
GMGabriel Martínez-Edo
Gabriel Martínez-Edo
ABAlba Balmori
Alba Balmori
IPIris Ponton
Iris Ponton
ARAndrea Martí del Rio
Andrea Martí del Rio
David Sánchez-GarcíaDavid Sánchez-García
David Sánchez-García
Mesoporous silica sieves are among the most studied nano-objects due to their stable pore structure and easy preparation. In particular, MCM-41 have attracted increasing research attention due to their chemical versatility. This review focuses on the synthesis and regioselective functionalization of MCM-41 to prepare catalytic systems. The topics covered are: mono and di-functionalized MCM-41 as basic and acid catalysts, catalysts based on metallic complexes and heteropolyacids supported onto MCM-41, metallic nanoparticles embed onto functionalized MCM-41 and magnetic MCM-41 for catalytic purposes.

9 December 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
IPIris Ponton
Iris Ponton
ARAndrea Martí del Rio
Andrea Martí del Rio
MGMarta Gómez Gómez
Marta Gómez Gómez
David Sánchez-GarcíaDavid Sánchez-García
David Sánchez-García
Combination therapies rely on the administration of more than one drug, with independent mechanisms of action, aiming to enhance the efficiency of the treatment. For an optimal performance, the implementation of such therapies requires the delivery of the correct combination of drugs to a specific cellular target. In this context, the use of nanoparticles (NP) as platforms for the co-delivery of multiple drugs is considered a highly promising strategy. In particular, mesoporous silica nanoparticles (MSN) have emerged as versatile building blocks to devise complex drug delivery systems (DDS). This review describes the design, synthesis, and application of MSNs to the delivery of multiple drugs including nucleic acids for combination therapies.

22 July 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
IPIris Ponton
Iris Ponton
David Sánchez-GarcíaDavid Sánchez-García
David Sánchez-García
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers worldwide, characterized by late diagnosis, aggressive progression, and poor response to conventional monotherapies. Combination therapies have emerged as a promising approach to overcome multidrug resistance (MDR), enhance efficacy, and target the complex tumor microenvironment (TME). Nanoparticle-based drug delivery systems (DDSs) have gained significant attention for their ability to co-deliver multiple agents with controlled release profiles. This review comprehensively examines nanoparticle-based platforms developed for PDAC combination therapies, focusing on small-molecule drugs. The systems discussed are drawn from studies published between 2005 and 2025.

29 November 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
IPIris Ponton
Iris Ponton
SNSandra Núñez
Sandra Núñez
CDCristina Díaz-Perlas
Cristina Díaz-Perlas
BOBenjamí Oller-Salvia
Benjamí Oller-Salvia
CSCarlos Semino
Carlos Semino
David Sánchez-GarcíaDavid Sánchez-García
David Sánchez-García